- © 2012 by American Society of Clinical Oncology
Author Corrections
The February 10, 2012, article by Munster et al, entitled “Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer” (J Clin Oncol 30:533–538, 2012), contained errors.
In Table 1, under Race, one Black and two Asian patients were listed in the control arm, whereas it should have been no Black and one Asian patient. Also, one Native American and one patient of unknown race should have been listed in the control arm. Under Ethnicity, the data were inadvertently transposed between Hispanic and Non-Hispanic patients. Both sections are reprinted below in their entirety with the corrected data given in bold:
